Iran Pro­duces Anti-Can­cer Drug to Neu­tral­ize U.S. Sanc­tions

Iran News - - DOMESTIC -

TEHRAN (IFP) - An Ira­nian sci­en­tist has man­aged to pro­duce an anti-can­cer drug whose scarcity, caused by the U.S. sanc­tions, had cre­ated prob­lems for the coun­try in the re­cent months.

Ira­nian Health Min­istry ear­lier an­nounced that the anti-can­cer drug called Busul­fan can­not be pro­vided for the pa­tients in the coun­try.

How­ever, Dr Nader Norouzi, a fac­ulty mem­ber at the Ur­mia Univer­sity of Med­i­cal Sciences, has now suc­ceeded in mak­ing the drug with a high de­gree of pu­rity us­ing a sim­ple method.

Ac­cord­ing to ISNA, the drug, which is ex­clu­sively pro­duced by the United States and France, is one of the most ex­pen­sive anti-can­cer med­i­ca­tions, which can now be mass-pro­duced in­side Iran.

“The Min­istry of Health asked the aca­demic cen­tres to pro­duce a to­tal of 160 es­sen­tial medicines in­clud­ing Busul­fan. Thank God af­ter months of ef­forts, the drug, which is used to treat chronic Leukemia, was suc­cess­fully pro­duced,” said Dr Norouzi.

Dr Norouzi also said that the price of this drug last year was about $150, but now the price can drop sig­nif­i­cantly while it is not just pro­duced by some par­tic­u­lar coun­tries any­more; there­fore, peo­ple should not worry about the drug at the time of sanc­tions.

The U.S. re­in­stated sanc­tions against Iran’s oil and bank­ing in­dus­try on Mon­day, fol­low­ing its with­drawal from the 2015 nu­clear deal and pledges that Wash­ing­ton will place max­i­mum pressure on Iran.

Hu­man­i­tar­ian sup­plies are for­mally ex­empted from sanc­tions, but the bank­ing sanc­tions

prac­ti­cally de­ter any kind of trade with Iran.

Newspapers in English

Newspapers from Iran

© PressReader. All rights reserved.